Generation Bio Co. (NASDAQ:GBIO) shares, rose in value on Friday, 08/05/22, with the stock price up by 0.37% to the previous day’s close as strong demand from buyers drove the stock to $8.08.
Actively observing the price movement in the last trading, the stock closed the session at $8.05, falling within a range of $7.86 and $8.16. The value of beta (5-year monthly) was 2.12. Referring to stock’s 52-week performance, its high was $28.67, and the low was $3.96. On the whole, GBIO has fluctuated by 12.38% over the past month.
With the market capitalization of Generation Bio Co. currently standing at about $495.30 million, investors are eagerly awaiting this quarter’s results, scheduled for Mar 16, 2022 – Mar 21, 2022. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.62, which is expected to increase to -$0.48 for fiscal year -$2.56 and then to about -$2.57 by fiscal year 2023. Data indicates that the EPS growth is expected to be -20.80% in 2023, while the next year’s EPS growth is forecast to be -0.40%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that GBIO’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of Hold while long term indicators on average have been pointing out that it is a Hold.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of GBIO currently trading nearly 16.64% and 26.06% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 66.69, while the 7-day volatility ratio is showing 8.09% which for the 30-day chart, stands at 8.02%. Furthermore, Generation Bio Co. (GBIO)’s average true range (ATR) is 0.54. The company’s stock has been forecasted to trade at an average price of $19.40 over the course of the next 52 weeks, with a low of $10.00 and a high of $29.00. Based on these price targets, the low is -23.76% off current price, whereas the price has to move -258.91% to reach the yearly target high. Additionally, analysts’ median price of $23.00 is likely to be welcomed by investors because it represents a decrease of -184.65% from the current levels.
Data on historical trading for Generation Bio Co. (NASDAQ:GBIO) indicates that the trading volumes over the past 10 days have averaged 0.47 million and over the past 3 months, they’ve averaged 355.08K. According to company’s latest data on outstanding shares, there are 57.00 million shares outstanding.
Nearly 3.30% of Generation Bio Co.’s shares belong to company insiders and institutional investors own 95.55% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 2.77 million shares as on Jul 14, 2022, resulting in a short ratio of 6.86. According to the data, the short interest in Generation Bio Co. (GBIO) stood at 4.85% of shares outstanding as of Jul 14, 2022; the number of short shares registered in Jun 14, 2022 reached 3.17 million. The stock has risen by 14.12% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the GBIO stock heading into the next quarter.